Pharmacotherapy for adults with overweight and obesity

  • Elizabeth Sturgiss*
  • , Lauren Ball
  • , David Blane
  • , Marita Hennessy
  • , Fiona Quigley
  • *Corresponding author for this work

Research output: Contribution to journalLetterResearch

Abstract

Although Qingyang Shi and colleagues’ systematic review and network meta-analysis of pharmacotherapy for overweight and obesity1 appears well conducted, we believe that the interpretation of the findings is not person-centred, and is perhaps even misleading, for several reasons.
Original languageEnglish
Pages (from-to)2100-2101
Number of pages2
JournalThe Lancet
Volume399
Issue number10341
DOIs
Publication statusPublished - 4 Jun 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Pharmacotherapy for adults with overweight and obesity'. Together they form a unique fingerprint.

Cite this